

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.88793667 |
| 2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.73290242 |
| 3 | heme biosynthetic process (GO:0006783) | 4.45418108 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.43996076 |
| 5 | response to peptidoglycan (GO:0032494) | 4.24257202 |
| 6 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.21982417 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 4.06383004 |
| 8 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.85524005 |
| 9 | tetrapyrrole biosynthetic process (GO:0033014) | 3.80345884 |
| 10 | NIK/NF-kappaB signaling (GO:0038061) | 3.77673419 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68888494 |
| 12 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.68884321 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 3.62604038 |
| 14 | blood vessel maturation (GO:0001955) | 3.61366315 |
| 15 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.60383955 |
| 16 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.54283740 |
| 17 | DNA strand elongation (GO:0022616) | 3.51028600 |
| 18 | DNA replication checkpoint (GO:0000076) | 3.49301110 |
| 19 | regulation of vitamin metabolic process (GO:0030656) | 3.47867725 |
| 20 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.45359765 |
| 21 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.39886849 |
| 22 | heme metabolic process (GO:0042168) | 3.38262492 |
| 23 | protein localization to kinetochore (GO:0034501) | 3.37444500 |
| 24 | myeloid dendritic cell differentiation (GO:0043011) | 3.35377088 |
| 25 | definitive hemopoiesis (GO:0060216) | 3.32880054 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31772401 |
| 27 | porphyrin-containing compound metabolic process (GO:0006778) | 3.30814662 |
| 28 | DNA replication initiation (GO:0006270) | 3.30401337 |
| 29 | response to thyroid hormone (GO:0097066) | 3.25665977 |
| 30 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.24897495 |
| 31 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.21575337 |
| 32 | type I interferon signaling pathway (GO:0060337) | 3.19445131 |
| 33 | cellular response to type I interferon (GO:0071357) | 3.19445131 |
| 34 | telomere maintenance via recombination (GO:0000722) | 3.18231280 |
| 35 | erythrocyte maturation (GO:0043249) | 3.17244239 |
| 36 | response to type I interferon (GO:0034340) | 3.15560180 |
| 37 | endothelial tube morphogenesis (GO:0061154) | 3.15312105 |
| 38 | morphogenesis of an endothelium (GO:0003159) | 3.15312105 |
| 39 | germinal center formation (GO:0002467) | 3.13552232 |
| 40 | T-helper 1 type immune response (GO:0042088) | 3.12842555 |
| 41 | response to protozoan (GO:0001562) | 3.12803391 |
| 42 | myeloid dendritic cell activation (GO:0001773) | 3.12755783 |
| 43 | pinocytosis (GO:0006907) | 3.12571404 |
| 44 | glycosphingolipid catabolic process (GO:0046479) | 3.12485591 |
| 45 | regulation of podosome assembly (GO:0071801) | 3.10964859 |
| 46 | lymph vessel development (GO:0001945) | 3.10712988 |
| 47 | macrophage activation involved in immune response (GO:0002281) | 3.07770950 |
| 48 | regulation of chemokine biosynthetic process (GO:0045073) | 3.03669194 |
| 49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.03572703 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.03572703 |
| 51 | protein localization to chromosome, centromeric region (GO:0071459) | 3.02936532 |
| 52 | regulation of chronic inflammatory response (GO:0002676) | 3.01685424 |
| 53 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.00399498 |
| 54 | mitotic recombination (GO:0006312) | 2.99898219 |
| 55 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.98917538 |
| 56 | positive regulation of respiratory burst (GO:0060267) | 2.98863552 |
| 57 | regulation of mononuclear cell migration (GO:0071675) | 2.98462874 |
| 58 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98196313 |
| 59 | modulation by symbiont of host defense response (GO:0052031) | 2.98196313 |
| 60 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98196313 |
| 61 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98196313 |
| 62 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98196313 |
| 63 | modulation by symbiont of host immune response (GO:0052553) | 2.98196313 |
| 64 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.96916335 |
| 65 | regulation of interferon-alpha production (GO:0032647) | 2.96309455 |
| 66 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93916694 |
| 67 | B cell mediated immunity (GO:0019724) | 2.91856655 |
| 68 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.91718219 |
| 69 | neutrophil activation involved in immune response (GO:0002283) | 2.91568447 |
| 70 | DNA unwinding involved in DNA replication (GO:0006268) | 2.89274765 |
| 71 | regulation of endothelial cell differentiation (GO:0045601) | 2.88989631 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88916958 |
| 73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.88747352 |
| 74 | regulation of spindle organization (GO:0090224) | 2.87578645 |
| 75 | keratan sulfate catabolic process (GO:0042340) | 2.86847730 |
| 76 | barbed-end actin filament capping (GO:0051016) | 2.85167503 |
| 77 | dendritic cell differentiation (GO:0097028) | 2.84449639 |
| 78 | mature B cell differentiation involved in immune response (GO:0002313) | 2.82677675 |
| 79 | folic acid metabolic process (GO:0046655) | 2.81919967 |
| 80 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.81477557 |
| 81 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.81400599 |
| 82 | mitotic metaphase plate congression (GO:0007080) | 2.79564532 |
| 83 | defense response to protozoan (GO:0042832) | 2.79511741 |
| 84 | nucleobase biosynthetic process (GO:0046112) | 2.78316794 |
| 85 | response to muramyl dipeptide (GO:0032495) | 2.77616671 |
| 86 | glycolipid catabolic process (GO:0019377) | 2.75068495 |
| 87 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.73627312 |
| 88 | angiogenesis involved in wound healing (GO:0060055) | 2.73210055 |
| 89 | oligosaccharide catabolic process (GO:0009313) | 2.73206708 |
| 90 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.72571420 |
| 91 | mitotic nuclear envelope disassembly (GO:0007077) | 2.71956745 |
| 92 | response to folic acid (GO:0051593) | 2.71815328 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.70950131 |
| 94 | opsonization (GO:0008228) | 2.70414149 |
| 95 | surfactant homeostasis (GO:0043129) | 2.70071222 |
| 96 | cellular response to nitric oxide (GO:0071732) | 2.69889081 |
| 97 | purine nucleobase biosynthetic process (GO:0009113) | 2.69251056 |
| 98 | cellular response to arsenic-containing substance (GO:0071243) | 2.65413475 |
| 99 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.64453367 |
| 100 | cellular response to lipopolysaccharide (GO:0071222) | 2.64406595 |
| 101 | positive regulation of interferon-alpha production (GO:0032727) | 2.64155998 |
| 102 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.62768977 |
| 103 | positive regulation of vasculogenesis (GO:2001214) | 2.62410821 |
| 104 | response to xenobiotic stimulus (GO:0009410) | 2.61630629 |
| 105 | regulation of response to interferon-gamma (GO:0060330) | 2.61360908 |
| 106 | CENP-A containing nucleosome assembly (GO:0034080) | 2.61319676 |
| 107 | endothelium development (GO:0003158) | 2.59998651 |
| 108 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.59030848 |
| 109 | positive regulation of B cell differentiation (GO:0045579) | 2.58995791 |
| 110 | amino sugar catabolic process (GO:0046348) | 2.58979120 |
| 111 | histone-serine phosphorylation (GO:0035404) | 2.58343675 |
| 112 | regulation of immunoglobulin secretion (GO:0051023) | 2.57830172 |
| 113 | telomere maintenance via telomere lengthening (GO:0010833) | 2.57306442 |
| 114 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.55352094 |
| 115 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.53811951 |
| 116 | IMP biosynthetic process (GO:0006188) | 2.53674653 |
| 117 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.53052635 |
| 118 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.52512000 |
| 119 | cellular response to molecule of bacterial origin (GO:0071219) | 2.52487702 |
| 120 | mitotic chromosome condensation (GO:0007076) | 2.52333702 |
| 121 | gas transport (GO:0015669) | 2.52201145 |
| 122 | venous blood vessel morphogenesis (GO:0048845) | 2.52060497 |
| 123 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.51051600 |
| 124 | T cell migration (GO:0072678) | 2.50561359 |
| 125 | protein localization to endosome (GO:0036010) | 2.49071975 |
| 126 | negative regulation of growth of symbiont in host (GO:0044130) | 2.48805804 |
| 127 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.48805804 |
| 128 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.48805804 |
| 129 | regulation of growth of symbiont in host (GO:0044126) | 2.48805804 |
| 130 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.47776017 |
| 131 | regulation of monocyte differentiation (GO:0045655) | 2.47577337 |
| 132 | valine metabolic process (GO:0006573) | 2.46539849 |
| 133 | modulation by symbiont of host cellular process (GO:0044068) | 2.45692115 |
| 134 | membrane disassembly (GO:0030397) | 2.45402379 |
| 135 | nuclear envelope disassembly (GO:0051081) | 2.45402379 |
| 136 | cellular response to interferon-gamma (GO:0071346) | 2.45333630 |
| 137 | regulation of interleukin-12 production (GO:0032655) | 2.44451225 |
| 138 | regulation of cholesterol storage (GO:0010885) | 2.43186067 |
| 139 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.42944687 |
| 140 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42365639 |
| 141 | DNA deamination (GO:0045006) | 2.42102295 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 2.41762399 |
| 143 | cellular extravasation (GO:0045123) | 2.40740306 |
| 144 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.39466865 |
| 145 | monocyte chemotaxis (GO:0002548) | 2.39269750 |
| 146 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.38599881 |
| 147 | low-density lipoprotein particle clearance (GO:0034383) | 2.38239459 |
| 148 | metaphase plate congression (GO:0051310) | 2.37902686 |
| 149 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.37486688 |
| 150 | myeloid cell activation involved in immune response (GO:0002275) | 2.36118123 |
| 151 | positive regulation of antigen processing and presentation (GO:0002579) | 2.34604024 |
| 152 | ceramide catabolic process (GO:0046514) | 2.34435061 |
| 153 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.34237327 |
| 154 | ribosomal small subunit assembly (GO:0000028) | 2.34130928 |
| 155 | chromatin remodeling at centromere (GO:0031055) | 2.33999545 |
| 156 | regulation of mitotic spindle organization (GO:0060236) | 2.33963159 |
| 157 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.33664190 |
| 158 | positive regulation of isotype switching (GO:0045830) | 2.33443163 |
| 159 | regulation of superoxide anion generation (GO:0032928) | 2.33440922 |
| 160 | regulation of B cell apoptotic process (GO:0002902) | 2.33435139 |
| 161 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.33335047 |
| 162 | peptide catabolic process (GO:0043171) | 2.33056379 |
| 163 | purine nucleotide salvage (GO:0032261) | 2.32245761 |
| 164 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.32090444 |
| 165 | response to interferon-gamma (GO:0034341) | 2.32064087 |
| 166 | DNA replication-independent nucleosome organization (GO:0034724) | 2.31873831 |
| 167 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.31873831 |
| 168 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.31731635 |
| 169 | positive regulation of B cell mediated immunity (GO:0002714) | 2.31731635 |
| 170 | kinetochore organization (GO:0051383) | 2.30731384 |
| 171 | tetrapyrrole metabolic process (GO:0033013) | 2.30649565 |
| 172 | cellular response to cadmium ion (GO:0071276) | 2.29647270 |
| 173 | response to nitric oxide (GO:0071731) | 2.29315986 |
| 174 | IMP metabolic process (GO:0046040) | 2.29097178 |
| 175 | ovulation from ovarian follicle (GO:0001542) | 2.28169996 |
| 176 | negative regulation of phagocytosis (GO:0050765) | 2.26641506 |
| 177 | regulation of vasculogenesis (GO:2001212) | 2.26050481 |
| 178 | defense response to fungus (GO:0050832) | 2.25365539 |
| 179 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.23561669 |
| 180 | regulation of complement activation (GO:0030449) | 2.22294668 |
| 181 | one-carbon compound transport (GO:0019755) | 2.21321808 |
| 182 | pigment biosynthetic process (GO:0046148) | 2.20117420 |
| 183 | homocysteine metabolic process (GO:0050667) | 2.19744839 |
| 184 | positive regulation of chromosome segregation (GO:0051984) | 2.19104569 |
| 185 | basement membrane organization (GO:0071711) | 2.18337977 |
| 186 | iron ion import (GO:0097286) | 2.17502599 |
| 187 | mitotic sister chromatid segregation (GO:0000070) | 2.17135178 |
| 188 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.16948740 |
| 189 | establishment of chromosome localization (GO:0051303) | 2.16171211 |
| 190 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.15812133 |
| 191 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.15428482 |
| 192 | lymphangiogenesis (GO:0001946) | 2.15310519 |
| 193 | hemoglobin metabolic process (GO:0020027) | 2.14032177 |
| 194 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.11718286 |
| 195 | erythrocyte differentiation (GO:0030218) | 2.11583594 |
| 196 | regulation of protein activation cascade (GO:2000257) | 2.10790918 |
| 197 | embryonic hemopoiesis (GO:0035162) | 2.10566282 |
| 198 | cellular hyperosmotic response (GO:0071474) | 2.09403145 |
| 199 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.08436647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.22678062 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.71132725 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.70827748 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.42374114 |
| 5 | * GATA1_22025678_ChIP-Seq_K562_Human | 2.93599077 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.92690639 |
| 7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.45813518 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.41755927 |
| 9 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.34800694 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.31677150 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27461039 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.23769845 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10804802 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.00374327 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89605278 |
| 16 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80564824 |
| 17 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.76890089 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74843231 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.74342962 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.72413842 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63500024 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.62199747 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59248362 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.56839106 |
| 25 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.56805551 |
| 26 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.54774282 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.54262703 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54087679 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.53532883 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52330399 |
| 31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.51477351 |
| 32 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.50288862 |
| 33 | * MYC_22102868_ChIP-Seq_BL_Human | 1.49200114 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.48032564 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.47838013 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47243856 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46429808 |
| 38 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.45979305 |
| 39 | GATA1_19941826_ChIP-Seq_K562_Human | 1.45907968 |
| 40 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43683920 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43542124 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42755910 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42706280 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.42589205 |
| 45 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41877384 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41509282 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.41219215 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.40780219 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40085245 |
| 50 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.37520411 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37258911 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.35638876 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.35073327 |
| 54 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34953780 |
| 55 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.34780844 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33774039 |
| 57 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32565266 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32202086 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32019215 |
| 60 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.30959912 |
| 61 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30703695 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29749527 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27549831 |
| 64 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.26767628 |
| 65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25863083 |
| 66 | * MAF_26560356_Chip-Seq_TH2_Human | 1.25026884 |
| 67 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24984254 |
| 68 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.24517223 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22843681 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22246382 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21942112 |
| 72 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21639809 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20685768 |
| 74 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20435526 |
| 75 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19868472 |
| 76 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.18598212 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18389118 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18244286 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17212069 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.17142659 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16466383 |
| 82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15238145 |
| 83 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14710236 |
| 84 | * MAF_26560356_Chip-Seq_TH1_Human | 1.13546733 |
| 85 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.13012920 |
| 86 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12345877 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11660439 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10823280 |
| 89 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10665994 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09839282 |
| 91 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09707433 |
| 92 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09459268 |
| 93 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09284786 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08933137 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08473435 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08364093 |
| 97 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08249257 |
| 98 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08026168 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06885054 |
| 100 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06748187 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06346596 |
| 102 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.05431122 |
| 103 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05015805 |
| 104 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03660571 |
| 105 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03123083 |
| 106 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.02476458 |
| 107 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02435781 |
| 108 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01353671 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.01198938 |
| 110 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00683205 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00199638 |
| 112 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99197133 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99193669 |
| 114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99038160 |
| 115 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98709264 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98450299 |
| 117 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98119958 |
| 118 | MYB_26560356_Chip-Seq_TH1_Human | 0.97636190 |
| 119 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97600259 |
| 120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97054279 |
| 121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97032736 |
| 122 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.96848701 |
| 123 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.95798445 |
| 124 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95238832 |
| 125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95057998 |
| 126 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.94727829 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94541810 |
| 128 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94357107 |
| 129 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.93816460 |
| 130 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.92959206 |
| 131 | * MYB_26560356_Chip-Seq_TH2_Human | 0.91523537 |
| 132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89961769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 3.87167130 |
| 2 | MP0010368_abnormal_lymphatic_system | 3.46275490 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.43938043 |
| 4 | MP0003656_abnormal_erythrocyte_physiolo | 3.17935971 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.13816056 |
| 6 | MP0003436_decreased_susceptibility_to | 3.12874997 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.90783374 |
| 8 | MP0006054_spinal_hemorrhage | 2.79382759 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.75333080 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.44108525 |
| 11 | MP0001879_abnormal_lymphatic_vessel | 2.42417247 |
| 12 | MP0005451_abnormal_body_composition | 2.42355042 |
| 13 | MP0005275_abnormal_skin_tensile | 2.40734923 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.36130937 |
| 15 | MP0004510_myositis | 2.35151136 |
| 16 | MP0001790_abnormal_immune_system | 2.34102015 |
| 17 | MP0005387_immune_system_phenotype | 2.34102015 |
| 18 | MP0003724_increased_susceptibility_to | 2.31173546 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.30151022 |
| 20 | MP0006082_CNS_inflammation | 2.29446870 |
| 21 | MP0005671_abnormal_response_to | 2.19078751 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.15371974 |
| 23 | MP0003111_abnormal_nucleus_morphology | 2.03916953 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.02814792 |
| 25 | MP0002723_abnormal_immune_serum | 1.94447541 |
| 26 | MP0001800_abnormal_humoral_immune | 1.93546940 |
| 27 | MP0001545_abnormal_hematopoietic_system | 1.92010709 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.92010709 |
| 29 | MP0004947_skin_inflammation | 1.77913915 |
| 30 | MP0004272_abnormal_basement_membrane | 1.77800036 |
| 31 | MP0003075_altered_response_to | 1.75557992 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.75153634 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.74199096 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.74061015 |
| 35 | MP0010094_abnormal_chromosome_stability | 1.73662470 |
| 36 | MP0001819_abnormal_immune_cell | 1.72448367 |
| 37 | MP0001958_emphysema | 1.68178086 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.63370954 |
| 39 | MP0002405_respiratory_system_inflammati | 1.60659049 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.54366357 |
| 41 | MP0000604_amyloidosis | 1.52775557 |
| 42 | MP0003077_abnormal_cell_cycle | 1.49316310 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.47807872 |
| 44 | MP0004084_abnormal_cardiac_muscle | 1.46957096 |
| 45 | MP0003828_pulmonary_edema | 1.45727658 |
| 46 | MP0004957_abnormal_blastocyst_morpholog | 1.44212919 |
| 47 | MP0000858_altered_metastatic_potential | 1.41628651 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.38893003 |
| 49 | MP0000716_abnormal_immune_system | 1.38506733 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.37469484 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.35837086 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.31334334 |
| 53 | MP0000343_altered_response_to | 1.28185841 |
| 54 | MP0003448_altered_tumor_morphology | 1.27239974 |
| 55 | MP0005023_abnormal_wound_healing | 1.26880875 |
| 56 | MP0003186_abnormal_redox_activity | 1.26026665 |
| 57 | MP0000749_muscle_degeneration | 1.26024078 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.22448463 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.22236166 |
| 60 | MP0003279_aneurysm | 1.21156024 |
| 61 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19806393 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.16350461 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.14834532 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.13891646 |
| 65 | MP0009840_abnormal_foam_cell | 1.13005414 |
| 66 | MP0008057_abnormal_DNA_replication | 1.12349018 |
| 67 | MP0005365_abnormal_bile_salt | 1.10893197 |
| 68 | MP0001661_extended_life_span | 1.10661535 |
| 69 | MP0000750_abnormal_muscle_regeneration | 1.10186574 |
| 70 | MP0000685_abnormal_immune_system | 1.09761826 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.09589639 |
| 72 | MP0005310_abnormal_salivary_gland | 1.09510409 |
| 73 | MP0008775_abnormal_heart_ventricle | 1.09224566 |
| 74 | MP0009764_decreased_sensitivity_to | 1.08665361 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.08215607 |
| 76 | MP0005166_decreased_susceptibility_to | 1.06841095 |
| 77 | MP0010307_abnormal_tumor_latency | 1.05577442 |
| 78 | MP0005330_cardiomyopathy | 1.04452375 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 1.03673188 |
| 80 | MP0000751_myopathy | 1.02817099 |
| 81 | MP0001544_abnormal_cardiovascular_syste | 1.01942019 |
| 82 | MP0005385_cardiovascular_system_phenoty | 1.01942019 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 1.00876378 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.99824929 |
| 85 | MP0009763_increased_sensitivity_to | 0.98361486 |
| 86 | MP0003091_abnormal_cell_migration | 0.97045544 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.96674142 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.96090587 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95503009 |
| 90 | MP0009785_altered_susceptibility_to | 0.93933721 |
| 91 | MP0000249_abnormal_blood_vessel | 0.93631225 |
| 92 | MP0001873_stomach_inflammation | 0.93600807 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.93237737 |
| 94 | MP0002398_abnormal_bone_marrow | 0.92712913 |
| 95 | MP0009278_abnormal_bone_marrow | 0.92384772 |
| 96 | MP0002722_abnormal_immune_system | 0.91606434 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.90977483 |
| 98 | MP0005360_urolithiasis | 0.90008572 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.89940311 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89330139 |
| 101 | MP0001853_heart_inflammation | 0.88995410 |
| 102 | MP0001835_abnormal_antigen_presentation | 0.88523828 |
| 103 | MP0000609_abnormal_liver_physiology | 0.87883860 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.87806558 |
| 105 | MP0005164_abnormal_response_to | 0.87612206 |
| 106 | MP0008260_abnormal_autophagy | 0.86727931 |
| 107 | MP0001756_abnormal_urination | 0.86705277 |
| 108 | MP0006138_congestive_heart_failure | 0.86466079 |
| 109 | MP0008007_abnormal_cellular_replicative | 0.85783943 |
| 110 | MP0002429_abnormal_blood_cell | 0.85682996 |
| 111 | MP0005670_abnormal_white_adipose | 0.84807473 |
| 112 | MP0003984_embryonic_growth_retardation | 0.83498738 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.83380974 |
| 114 | MP0000490_abnormal_crypts_of | 0.83372218 |
| 115 | MP0003763_abnormal_thymus_physiology | 0.83358297 |
| 116 | MP0002128_abnormal_blood_circulation | 0.83306281 |
| 117 | MP0002060_abnormal_skin_morphology | 0.83266588 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.82921784 |
| 119 | MP0002877_abnormal_melanocyte_morpholog | 0.82853697 |
| 120 | MP0010630_abnormal_cardiac_muscle | 0.82458091 |
| 121 | MP0005025_abnormal_response_to | 0.82234803 |
| 122 | MP0002088_abnormal_embryonic_growth/wei | 0.81230086 |
| 123 | MP0001730_embryonic_growth_arrest | 0.81219943 |
| 124 | MP0009643_abnormal_urine_homeostasis | 0.81218913 |
| 125 | MP0002254_reproductive_system_inflammat | 0.80300473 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.80280268 |
| 127 | MP0000598_abnormal_liver_morphology | 0.80202127 |
| 128 | MP0002086_abnormal_extraembryonic_tissu | 0.80171813 |
| 129 | MP0001542_abnormal_bone_strength | 0.79974259 |
| 130 | MP0008469_abnormal_protein_level | 0.79563787 |
| 131 | MP0005165_increased_susceptibility_to | 0.79222859 |
| 132 | MP0002108_abnormal_muscle_morphology | 0.78884245 |
| 133 | MP0003950_abnormal_plasma_membrane | 0.78769545 |
| 134 | MP0002006_tumorigenesis | 0.78655039 |
| 135 | MP0003303_peritoneal_inflammation | 0.78226719 |
| 136 | MP0000703_abnormal_thymus_morphology | 0.77648202 |
| 137 | MP0002419_abnormal_innate_immunity | 0.77396146 |
| 138 | MP0001243_abnormal_dermal_layer | 0.77200761 |
| 139 | MP0010329_abnormal_lipoprotein_level | 0.76783440 |
| 140 | MP0001915_intracranial_hemorrhage | 0.74747646 |
| 141 | MP0008004_abnormal_stomach_pH | 0.71282553 |
| 142 | MP0000371_diluted_coat_color | 0.70045453 |
| 143 | MP0003795_abnormal_bone_structure | 0.69057359 |
| 144 | MP0005390_skeleton_phenotype | 0.65897831 |
| 145 | MP0000313_abnormal_cell_death | 0.65265222 |
| 146 | MP0009697_abnormal_copulation | 0.63419337 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.61870749 |
| 148 | MP0005647_abnormal_sex_gland | 0.61134855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.73299985 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.73299985 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.73299985 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.59969565 |
| 5 | Polycythemia (HP:0001901) | 4.96315018 |
| 6 | Poikilocytosis (HP:0004447) | 3.99971586 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 3.98517682 |
| 8 | Spontaneous hematomas (HP:0007420) | 3.85842431 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.75988007 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.75463978 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.71863852 |
| 12 | Loss of speech (HP:0002371) | 3.58833883 |
| 13 | Ileus (HP:0002595) | 3.50766942 |
| 14 | Ankle contracture (HP:0006466) | 3.41677638 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.38633752 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.37848425 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.28271070 |
| 18 | Nonimmune hydrops fetalis (HP:0001790) | 3.25247796 |
| 19 | Diaphragmatic weakness (HP:0009113) | 3.23112896 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.20078735 |
| 21 | Microcytic anemia (HP:0001935) | 3.15001453 |
| 22 | Hematochezia (HP:0002573) | 3.14521170 |
| 23 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.14286451 |
| 24 | Nausea (HP:0002018) | 3.10196761 |
| 25 | Recurrent viral infections (HP:0004429) | 3.08958158 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.07542721 |
| 27 | Protrusio acetabuli (HP:0003179) | 3.04432081 |
| 28 | Congenital, generalized hypertrichosis (HP:0004540) | 3.03838855 |
| 29 | Premature rupture of membranes (HP:0001788) | 2.94970587 |
| 30 | Cholecystitis (HP:0001082) | 2.88800818 |
| 31 | Abnormal gallbladder physiology (HP:0012438) | 2.88800818 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 2.79449838 |
| 33 | Myocardial infarction (HP:0001658) | 2.78741308 |
| 34 | Hypoglycemic coma (HP:0001325) | 2.78518639 |
| 35 | Conjunctival telangiectasia (HP:0000524) | 2.74060588 |
| 36 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.72734244 |
| 37 | Orchitis (HP:0100796) | 2.71961777 |
| 38 | Petechiae (HP:0000967) | 2.67344954 |
| 39 | Cervical subluxation (HP:0003308) | 2.65639776 |
| 40 | Hepatosplenomegaly (HP:0001433) | 2.65306821 |
| 41 | Osteolytic defects of the hand bones (HP:0009699) | 2.63876404 |
| 42 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.63876404 |
| 43 | Myositis (HP:0100614) | 2.62907552 |
| 44 | Increased connective tissue (HP:0009025) | 2.60856520 |
| 45 | Broad metatarsal (HP:0001783) | 2.54370306 |
| 46 | Birth length less than 3rd percentile (HP:0003561) | 2.53578481 |
| 47 | Disinhibition (HP:0000734) | 2.53556613 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.52685289 |
| 49 | Optic neuritis (HP:0100653) | 2.52685289 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52012067 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51165508 |
| 52 | Obstructive lung disease (HP:0006536) | 2.51165508 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45188149 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45188149 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45188149 |
| 56 | Hypertensive crisis (HP:0100735) | 2.44817005 |
| 57 | Fatigue (HP:0012378) | 2.44660077 |
| 58 | Enlarged penis (HP:0000040) | 2.43459642 |
| 59 | Reticulocytosis (HP:0001923) | 2.43065949 |
| 60 | Hepatocellular carcinoma (HP:0001402) | 2.41016693 |
| 61 | Wrist flexion contracture (HP:0001239) | 2.40876366 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.39525817 |
| 63 | Nuclear cataract (HP:0100018) | 2.38431513 |
| 64 | Stomatitis (HP:0010280) | 2.37426212 |
| 65 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.34154418 |
| 66 | Muscle fiber splitting (HP:0003555) | 2.28993631 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.28900674 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28900674 |
| 69 | Meningitis (HP:0001287) | 2.28771308 |
| 70 | Axonal loss (HP:0003447) | 2.28176887 |
| 71 | Esophageal varix (HP:0002040) | 2.27858059 |
| 72 | Abnormal number of erythroid precursors (HP:0012131) | 2.27851813 |
| 73 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.26880067 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.26709836 |
| 75 | Upper motor neuron abnormality (HP:0002127) | 2.26157422 |
| 76 | Acanthocytosis (HP:0001927) | 2.23657009 |
| 77 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23605291 |
| 78 | Increased IgM level (HP:0003496) | 2.23378321 |
| 79 | Increased IgE level (HP:0003212) | 2.21907862 |
| 80 | High pitched voice (HP:0001620) | 2.20818468 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.18894352 |
| 82 | Abnormality of reticulocytes (HP:0004312) | 2.16860742 |
| 83 | Complement deficiency (HP:0004431) | 2.16685269 |
| 84 | Increased serum ferritin (HP:0003281) | 2.16340307 |
| 85 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.16177095 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.15851589 |
| 87 | Deep venous thrombosis (HP:0002625) | 2.15188089 |
| 88 | Abnormality of complement system (HP:0005339) | 2.14371902 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.13975354 |
| 90 | Vasculitis (HP:0002633) | 2.13457901 |
| 91 | Glomerulonephritis (HP:0000099) | 2.11657813 |
| 92 | Hypertriglyceridemia (HP:0002155) | 2.08387683 |
| 93 | Ragged-red muscle fibers (HP:0003200) | 2.07805565 |
| 94 | Interstitial pulmonary disease (HP:0006530) | 2.07617550 |
| 95 | Lipoatrophy (HP:0100578) | 2.07524629 |
| 96 | IgA deficiency (HP:0002720) | 2.07173447 |
| 97 | Diminished motivation (HP:0000745) | 2.05849324 |
| 98 | Autoimmune thrombocytopenia (HP:0001973) | 2.05195380 |
| 99 | Breast hypoplasia (HP:0003187) | 2.05069343 |
| 100 | Neurofibrillary tangles (HP:0002185) | 2.04892992 |
| 101 | Apathy (HP:0000741) | 2.04617612 |
| 102 | Mucosal telangiectasiae (HP:0100579) | 2.03074888 |
| 103 | Mutism (HP:0002300) | 2.03031774 |
| 104 | B lymphocytopenia (HP:0010976) | 2.02849306 |
| 105 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.02579086 |
| 106 | Personality changes (HP:0000751) | 2.01448090 |
| 107 | Combined immunodeficiency (HP:0005387) | 2.00737902 |
| 108 | Epistaxis (HP:0000421) | 1.97972060 |
| 109 | Colitis (HP:0002583) | 1.97472134 |
| 110 | Hypochromic anemia (HP:0001931) | 1.97454560 |
| 111 | Hypochromic microcytic anemia (HP:0004840) | 1.97374707 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.97285630 |
| 113 | Recurrent skin infections (HP:0001581) | 1.96639288 |
| 114 | Neoplasm of head and neck (HP:0012288) | 1.95830236 |
| 115 | Esophageal neoplasm (HP:0100751) | 1.95830236 |
| 116 | Paralysis (HP:0003470) | 1.94874207 |
| 117 | Pustule (HP:0200039) | 1.94067069 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.92702110 |
| 119 | Hyperbilirubinemia (HP:0002904) | 1.92672162 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 1.91530185 |
| 121 | Agammaglobulinemia (HP:0004432) | 1.90570643 |
| 122 | Keratoconjunctivitis sicca (HP:0001097) | 1.90272813 |
| 123 | Progressive neurologic deterioration (HP:0002344) | 1.89896041 |
| 124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89807033 |
| 125 | Thrombocytosis (HP:0001894) | 1.89323462 |
| 126 | Insulin resistance (HP:0000855) | 1.89114767 |
| 127 | Spinal rigidity (HP:0003306) | 1.88276012 |
| 128 | Abnormal platelet function (HP:0011869) | 1.88138551 |
| 129 | Impaired platelet aggregation (HP:0003540) | 1.88138551 |
| 130 | Cerebral aneurysm (HP:0004944) | 1.86593485 |
| 131 | Multiple enchondromatosis (HP:0005701) | 1.85641331 |
| 132 | Entropion (HP:0000621) | 1.84872908 |
| 133 | Mitral stenosis (HP:0001718) | 1.84806424 |
| 134 | Neonatal death (HP:0003811) | 1.84617317 |
| 135 | Amaurosis fugax (HP:0100576) | 1.84489205 |
| 136 | Ventricular tachycardia (HP:0004756) | 1.84311866 |
| 137 | Urticaria (HP:0001025) | 1.83611061 |
| 138 | Osteomyelitis (HP:0002754) | 1.83276240 |
| 139 | Thoracic kyphosis (HP:0002942) | 1.82822450 |
| 140 | Aortic aneurysm (HP:0004942) | 1.82764746 |
| 141 | Amyloidosis (HP:0011034) | 1.82656518 |
| 142 | Cholelithiasis (HP:0001081) | 1.82622046 |
| 143 | Abnormality of B cell number (HP:0010975) | 1.82465122 |
| 144 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.81964708 |
| 145 | Absent epiphyses (HP:0010577) | 1.81964708 |
| 146 | Rough bone trabeculation (HP:0100670) | 1.81614323 |
| 147 | Slender build (HP:0001533) | 1.81334267 |
| 148 | Agnosia (HP:0010524) | 1.81209234 |
| 149 | Prolonged neonatal jaundice (HP:0006579) | 1.81204302 |
| 150 | Gangrene (HP:0100758) | 1.80960633 |
| 151 | Vertebral compression fractures (HP:0002953) | 1.78854710 |
| 152 | Large hands (HP:0001176) | 1.78208707 |
| 153 | Granulocytopenia (HP:0001913) | 1.77095164 |
| 154 | Acrocyanosis (HP:0001063) | 1.75426012 |
| 155 | Pulmonary artery stenosis (HP:0004415) | 1.74663083 |
| 156 | Aortic dissection (HP:0002647) | 1.74183731 |
| 157 | Abnormality of the intrinsic pathway (HP:0010989) | 1.72421142 |
| 158 | Chronic otitis media (HP:0000389) | 1.72080889 |
| 159 | Thrombophlebitis (HP:0004418) | 1.71957541 |
| 160 | Aortic valve stenosis (HP:0001650) | 1.71744583 |
| 161 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71712886 |
| 162 | Cellulitis (HP:0100658) | 1.70877861 |
| 163 | Ureteral duplication (HP:0000073) | 1.70698964 |
| 164 | Eosinophilia (HP:0001880) | 1.70678797 |
| 165 | Reticulocytopenia (HP:0001896) | 1.70273708 |
| 166 | Chondrocalcinosis (HP:0000934) | 1.68809211 |
| 167 | Growth hormone excess (HP:0000845) | 1.68397929 |
| 168 | Abnormality of the umbilical cord (HP:0010881) | 1.68271605 |
| 169 | Purpura (HP:0000979) | 1.66966544 |
| 170 | Long foot (HP:0001833) | 1.65920334 |
| 171 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.65571602 |
| 172 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.63142669 |
| 173 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.60065586 |
| 174 | Dicarboxylic aciduria (HP:0003215) | 1.60065586 |
| 175 | Eczematoid dermatitis (HP:0000976) | 1.59437864 |
| 176 | Gastrointestinal dysmotility (HP:0002579) | 1.59055595 |
| 177 | Generalized amyotrophy (HP:0003700) | 1.58017548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.52662733 |
| 2 | KDR | 3.36111884 |
| 3 | INSRR | 3.19935407 |
| 4 | MAP3K14 | 2.97017927 |
| 5 | PRPF4B | 2.91533539 |
| 6 | EIF2AK1 | 2.88188955 |
| 7 | TGFBR2 | 2.75732231 |
| 8 | BUB1 | 2.68388002 |
| 9 | WEE1 | 2.61418317 |
| 10 | TAOK2 | 2.59931575 |
| 11 | RIPK4 | 2.49139648 |
| 12 | CDC7 | 2.20954833 |
| 13 | TGFBR1 | 2.07369685 |
| 14 | TESK2 | 2.00384580 |
| 15 | TRPM7 | 1.92120191 |
| 16 | BLK | 1.84997632 |
| 17 | TRIB3 | 1.81163247 |
| 18 | NME2 | 1.80978602 |
| 19 | ERN1 | 1.72272207 |
| 20 | MATK | 1.68862068 |
| 21 | MAP2K3 | 1.65949452 |
| 22 | GRK7 | 1.57601214 |
| 23 | BRSK2 | 1.56809462 |
| 24 | PLK4 | 1.54300329 |
| 25 | NEK2 | 1.53890982 |
| 26 | TTN | 1.53865570 |
| 27 | STK10 | 1.52423952 |
| 28 | ZAK | 1.51227961 |
| 29 | FLT3 | 1.50816362 |
| 30 | TYK2 | 1.49338076 |
| 31 | DDR2 | 1.47930563 |
| 32 | MOS | 1.45852248 |
| 33 | MAP3K13 | 1.45317037 |
| 34 | FGFR4 | 1.45177197 |
| 35 | MAP4K1 | 1.42318108 |
| 36 | STK4 | 1.39598760 |
| 37 | PIM2 | 1.38873069 |
| 38 | SMG1 | 1.38386492 |
| 39 | BCKDK | 1.33917602 |
| 40 | ICK | 1.30208367 |
| 41 | JAK3 | 1.29379987 |
| 42 | ACVR1B | 1.24529793 |
| 43 | PKN2 | 1.23401051 |
| 44 | EEF2K | 1.21634003 |
| 45 | NEK9 | 1.15055645 |
| 46 | VRK1 | 1.13795509 |
| 47 | BMPR2 | 1.13533246 |
| 48 | LRRK2 | 1.13176251 |
| 49 | ZAP70 | 1.11298744 |
| 50 | ARAF | 1.10666484 |
| 51 | NEK1 | 1.10456417 |
| 52 | RPS6KA4 | 1.09521480 |
| 53 | MAP3K3 | 1.06926404 |
| 54 | CCNB1 | 1.05375016 |
| 55 | PIM1 | 1.05279487 |
| 56 | SIK3 | 1.04055425 |
| 57 | TESK1 | 1.03343074 |
| 58 | KIT | 1.02308132 |
| 59 | EIF2AK3 | 1.00627250 |
| 60 | TEC | 1.00490704 |
| 61 | TSSK6 | 1.00185800 |
| 62 | CDK12 | 0.99836852 |
| 63 | IRAK3 | 0.99595100 |
| 64 | STK24 | 0.99434664 |
| 65 | VRK2 | 0.99330551 |
| 66 | AURKB | 0.99324274 |
| 67 | CDK4 | 0.99016897 |
| 68 | MAP3K8 | 0.96570351 |
| 69 | FGR | 0.95800058 |
| 70 | MYLK | 0.93973802 |
| 71 | CSK | 0.92469351 |
| 72 | STK3 | 0.92347017 |
| 73 | SYK | 0.92334708 |
| 74 | TTK | 0.92226538 |
| 75 | PINK1 | 0.91461905 |
| 76 | TAOK3 | 0.88712687 |
| 77 | PDGFRA | 0.88535321 |
| 78 | MAP3K1 | 0.87740570 |
| 79 | CDC42BPA | 0.86921921 |
| 80 | BRSK1 | 0.83870351 |
| 81 | EPHB1 | 0.83711901 |
| 82 | EPHA3 | 0.82782269 |
| 83 | RIPK1 | 0.82574661 |
| 84 | TAOK1 | 0.81706586 |
| 85 | PLK1 | 0.81439968 |
| 86 | STK16 | 0.81180683 |
| 87 | ATR | 0.78007028 |
| 88 | JAK1 | 0.76514187 |
| 89 | TXK | 0.74304251 |
| 90 | LYN | 0.73930995 |
| 91 | PAK4 | 0.73605357 |
| 92 | MARK3 | 0.70893411 |
| 93 | TBK1 | 0.69841217 |
| 94 | CSF1R | 0.64918296 |
| 95 | CHUK | 0.64266127 |
| 96 | JAK2 | 0.63336521 |
| 97 | CDK7 | 0.63325111 |
| 98 | IRAK4 | 0.63044257 |
| 99 | MAP3K10 | 0.59931585 |
| 100 | MAP3K5 | 0.59749030 |
| 101 | EIF2AK2 | 0.59562476 |
| 102 | DYRK3 | 0.59012053 |
| 103 | SIK2 | 0.56866202 |
| 104 | RAF1 | 0.54011988 |
| 105 | MAPK11 | 0.53981118 |
| 106 | ILK | 0.53743408 |
| 107 | ABL2 | 0.53249197 |
| 108 | PDK2 | 0.52498964 |
| 109 | LCK | 0.50716259 |
| 110 | BTK | 0.50608699 |
| 111 | MKNK1 | 0.50580068 |
| 112 | NLK | 0.50004399 |
| 113 | BMX | 0.49793632 |
| 114 | CAMK1D | 0.49773788 |
| 115 | PBK | 0.49679030 |
| 116 | RPS6KB2 | 0.49485089 |
| 117 | HCK | 0.48227368 |
| 118 | PDK3 | 0.48116194 |
| 119 | PDK4 | 0.48116194 |
| 120 | MAPK12 | 0.48052308 |
| 121 | CDK6 | 0.47931425 |
| 122 | IKBKE | 0.47795554 |
| 123 | FGFR3 | 0.46706740 |
| 124 | AURKA | 0.46688175 |
| 125 | SRPK1 | 0.45832987 |
| 126 | BRAF | 0.45451208 |
| 127 | PLK3 | 0.44402372 |
| 128 | SIK1 | 0.43947632 |
| 129 | SCYL2 | 0.42232469 |
| 130 | MST1R | 0.42145347 |
| 131 | MAPKAPK3 | 0.42040295 |
| 132 | IKBKB | 0.41117179 |
| 133 | HIPK2 | 0.41049982 |
| 134 | MAP3K6 | 0.39749809 |
| 135 | RPS6KA5 | 0.38255346 |
| 136 | DAPK1 | 0.38212482 |
| 137 | MAP3K11 | 0.38137058 |
| 138 | MAPKAPK2 | 0.38024475 |
| 139 | PAK1 | 0.37622334 |
| 140 | PTK6 | 0.37575175 |
| 141 | ALK | 0.37330437 |
| 142 | CLK1 | 0.36731998 |
| 143 | MAPK4 | 0.36080074 |
| 144 | EPHA2 | 0.34919778 |
| 145 | PDPK1 | 0.33980709 |
| 146 | CHEK2 | 0.33847166 |
| 147 | IRAK2 | 0.30269859 |
| 148 | FES | 0.29877190 |
| 149 | MTOR | 0.27060222 |
| 150 | CHEK1 | 0.26610241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.25559616 |
| 2 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.84779190 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.48242388 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 2.43041906 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.42482465 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.40864760 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.40844399 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.27434812 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23113103 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.19997044 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.14950059 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 2.08385015 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 2.03351401 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01004700 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96059582 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86268687 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84468266 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82732513 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.79495315 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.75738277 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72766637 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.71092076 |
| 23 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.65902396 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62967705 |
| 25 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.61686024 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.55694606 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50449833 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47872372 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44697811 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42670403 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40855224 |
| 32 | RNA transport_Homo sapiens_hsa03013 | 1.40181184 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.37620702 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.37115338 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35063033 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.33863595 |
| 37 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.33836183 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.24561077 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23976540 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23819433 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.22988589 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.22849320 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 1.22801569 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21747089 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.21128193 |
| 46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20605280 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.20365414 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.20351045 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 1.18367471 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17606251 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 1.15763706 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15366744 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 1.13609336 |
| 54 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.13257409 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08682196 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06945660 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05176119 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05047021 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 1.02488449 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.01944477 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01070185 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00227330 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98986444 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.96128920 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94521770 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94394437 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93252332 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92874277 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.91845039 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90160940 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88999966 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88604357 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88031745 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87967302 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87897877 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86979377 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84866503 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81680102 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78900463 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78394737 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78132485 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76957176 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.75080136 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74866572 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73326076 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73205561 |
| 87 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72786184 |
| 88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.72769860 |
| 89 | Legionellosis_Homo sapiens_hsa05134 | 0.72453797 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72060692 |
| 91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71375558 |
| 92 | Measles_Homo sapiens_hsa05162 | 0.70631000 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70553853 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.70544364 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68644102 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67927180 |
| 97 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66116418 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65961913 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.65814054 |
| 100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.65531100 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64374339 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64204602 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.63149876 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62814733 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62104339 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62016991 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61998575 |
| 108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60752218 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60342790 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59983924 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59838258 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59152823 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.58224445 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57359050 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.56732431 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56509382 |
| 117 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55790271 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54909715 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.54602879 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52092953 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51282359 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49450290 |
| 123 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49138350 |
| 124 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47998234 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46475245 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.45467714 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42527122 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42414331 |
| 129 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42235879 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42035481 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40727337 |
| 132 | Influenza A_Homo sapiens_hsa05164 | 0.40485812 |
| 133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40424647 |
| 134 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40250807 |
| 135 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39822043 |
| 136 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39723784 |
| 137 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39514130 |
| 138 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39394313 |
| 139 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39037300 |
| 140 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36387853 |
| 141 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30861686 |
| 142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28892876 |
| 143 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26723288 |

